Analytical Data
-
基因名
CEACAM8
- Application
-
别名
CEACAM8；CGM6；Carcinoembryonic antigen-related cell adhesion molecule 8
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P31997
-
表达区间
1-319aa
-
氨基酸序列
MGPISAPSCR WRIPWQGLLL TASLFTFWNP PTTAQLTIEA VPSNAAEGKE VLLLVHNLPQ DPRGYNWYKG ETVDANRRII GYVISNQQIT PGPAYSNRET IYPNASLLMR NVTRNDTGSY TLQVIKLNLM SEEVTGQFSV HPETPKPSIS SNNSNPVEDK DAVAFTCEPE TQNTTYLWWV NGQSLPVSPR LQLSNGNRTL TLLSVTRNDV GPYECEIQNP ASANFSDPVT LNVLYGPDAP TISPSDTYYH AGVNLNLSCH AASNPPSQYS WSVNGTFQQY TQKLFIPNIT TKNSGSYACH TTNSATGRNR TTVRMITVS
-
分子量
33 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CEACAM8, or Carcinoembryonic Antigen-Related Cell Adhesion Molecule 8, is a member of the CEACAM family, which plays a significant role in immune responses and cell adhesion processes. Research into CEACAM8 has gained attention due to its involvement in various physiological and pathological conditions, particularly in the context of inflammatory diseases and certain types of cancer. CEACAM8 is primarily expressed on neutrophils and has been implicated in the regulation of neutrophil activation and migration, making it a potential biomarker for infections and inflammatory states. Furthermore, its interactions with other CEACAM family members and pathogens suggest a complex role in host defense mechanisms. The development of recombinant CEACAM8 provides a valuable tool for studying its functional properties, exploring its role in leukocyte biology, and evaluating its potential as a therapeutic target or diagnostic marker. Characterizing this protein can enhance our understanding of immune system dynamics and contribute to the advancement of targeted therapies for diseases where CEACAM8 is a key player. As such, recombinant CEACAM8 is vital for elucidating its biological roles and paving the way for innovative clinical applications.
